Phase II Trial of Vandetanib (ZD6474, Caprelsa) in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Vandetanib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 07 Jan 2020 Status changed from discontinued to completed as reported by ClinicalTrials.gov record.
- 22 Aug 2019 Results published in the Clinical Cancer Research
- 22 Aug 2019 Status changed from active, no longer recruiting to discontinued according to results published in the Clinical Cancer Research.